Phreesia Inc (PHR)

DataMEDS AI, Inc. (NASDAQ: $MEDS ) has settled litigation tied to the May 2023 Wellgistics, LLC purchase agreement, extinguishing liabilities of approximately $19 million that had been carried on its balance sheet. The Tampa-based Health IT company pairs its EinsteinRx artificial intelligence platform and PharmacyChain smart contracts platform with pharmacy, pharmaceutical-adjacent and telemedicine business units. DataMEDS AI, Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/datameds-ai-inc-1 The consideration came in two parts, cash and retired shares, with the full terms in the company's SEC filing: • 364,099 shares of DataMEDS common stock were retired as part of the settlement agreement. • The company paid a total of $450,000 in cash for the settlement. • Additional terms are set out in a Form 8-K filed with the SEC and linked in the release. Regarding the company's focus following the settlement, Gerald E. Commissiong, Interim Co-CEO of DataMEDS, stated: "The Company is pleased to put this outstanding litigation behind it so it can focus on solving healthcare's biggest challenges for our clients through the vertical integration of healthcare delivery, and the compliant tokenization of pharmaceutical supply tracking and patient data." Read the full release: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/datameds-ai-litigation-settlement-extinguishes-19-million-in-liabilit-1223546 DataMeds AI, Inc. (NASDAQ:MEDS) (formerly Wellgistics Health, Inc.) is a leading Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy and pharmacy services, including the distribution of products developed by Tollo Health, LLC. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $OPRX, $HCAT, $PHR, $XLV

$PHR don’t sleep on this one

I looked at the business behind $PHR (Phreesia, Inc.) for you. Based on financial data and reported results. #PHR

$PHR You LONGS please reply on the following: This is going to be long but worth it maybe: Ready? The offering.. October 2020 Offering: 5,750,000 primary shares sold at $32.00 = $184,000,000

$PHR - Phreesia Inc - 10Q - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +1919.7% above peer average (30,780 vs 1,524 across 714 peers). PHR flags new risks from dependence on securitization and additional capital to fund patient receivables, execution risk on restructuring-driven cost savings, and expanding AI-related threats including client adoption of cheaper/integrated AI tools, data leakage, evolving global AI regulation (notably EU AI Act), compliance exposure, and potential scrutiny of its AI marketing claims. #HealthcareTechnology #AIIntegration #SecuritizationRisk #RegulatoryCompliance #CostRestructuring 🟢 Added 🟠 Removed https://d-risk.ai/PHR/10-Q/2026-09-03

Top Losing Stocks Today, Sep 3, 2026: $CPB Closed $21.26, Down 10.8% $TSN Down ~7% $VSXY Down 12% $MEI Down 12% $PHR Down ~4% https://truthsandnews.com/markets/top-losing-stocks-today-sep-3-2026-rare-ciena-polestar

$PHR buying opp.

$NEI $NTAP $PHR $AI AFTER-HOURS MOVERS: Currently Higher After Earnings: - Tilly's (TLYS) up 36.5% - Snowflake (SNOW) up 23.1% - Netskope (NTSK) up 12.9% - Argan (AGX) up 7.9% - Five Below (FIVE) up 4.9% Currently Lower After Earnings: - Methode Electronics (MEI) down 14.6% - NetApp (NTAP) down 8.7% - Phreesia (PHR) down 6.7% - Hewlett Packard Enterprise (HPE) down 5.2% - C3 AI (AI) down 1.4% - Broadcom (AVGO) down 0.8% Currently Also Lower: - Ultragenyx (RARE) down 43.3% after announcing Phase 3 Angelman syndrome missed all endpoints.

$PHR I liked the ER, picked up some shares

https://www.marketbeat.com/earnings/reports/2026-9-2-phreesia-inc-stock/ $PHR Phreesia Earnings Transcript